1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Hydrogels - Pipeline Review, 2015

Hydrogels - Pipeline Review, 2015

  • September 2015
  • -
  • GlobalData
  • -
  • 109 pages

Hydrogels - Pipeline Review, 2015

Summary

GlobalData's Medical Devices sector report, “Hydrogels - Pipeline Review, 2015" provides an overview of Hydrogels currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hydrogels pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Hydrogels under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Hydrogels and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Hydrogels under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Hydrogels - Pipeline Review, 2015
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 9
2 Introduction 10
2.1 Hydrogels Overview 10
3 Products under Development 11
3.1 Hydrogels - Pipeline Products by Stage of Development 11
3.2 Hydrogels - Pipeline Products by Segment 12
3.3 Hydrogels - Pipeline Products by Territory 13
3.4 Hydrogels - Pipeline Products by Regulatory Path 14
3.5 Hydrogels - Pipeline Products by Estimated Approval Date 15
3.6 Hydrogels - Ongoing Clinical Trials 16
4 Hydrogels - Pipeline Products under Development by Companies 17
4.1 Hydrogels Companies - Pipeline Products by Stage of Development 17
4.2 Hydrogels - Pipeline Products by Stage of Development 19
5 Hydrogels Companies and Product Overview 21
5.1 3QMatrix, Inc. Company Overview 21
5.1.1 3QMatrix, Inc. Pipeline Products and Ongoing Clinical Trials Overview 21
5.2 Abeona Therapeutics, Inc. Company Overview 22
5.2.1 Abeona Therapeutics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 22
5.3 Alafair Biosciences, Inc. Company Overview 24
5.3.1 Alafair Biosciences, Inc. Pipeline Products and Ongoing Clinical Trials Overview 24
5.4 Asana Medical, Inc. Company Overview 29
5.4.1 Asana Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 29
5.5 BioCure, Inc. Company Overview 30
5.5.1 BioCure, Inc. Pipeline Products and Ongoing Clinical Trials Overview 30
5.6 Biomendics, LLC Company Overview 34
5.6.1 Biomendics, LLC Pipeline Products and Ongoing Clinical Trials Overview 34
5.7 BioTime, Inc. Company Overview 35
5.7.1 BioTime, Inc. Pipeline Products and Ongoing Clinical Trials Overview 35
5.8 Brigham and Women's Hospital Company Overview 37
5.8.1 Brigham and Women's Hospital Pipeline Products and Ongoing Clinical Trials Overview 37
5.9 CelaCare Technologies, Inc. Company Overview 38
5.9.1 CelaCare Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 38
5.10 Chi2Gel Ltd. Company Overview 41
5.10.1 Chi2Gel Ltd. Pipeline Products and Ongoing Clinical Trials Overview 41
5.11 Consejo Superior de Investigaciones Cientificas Company Overview 42
5.11.1 Consejo Superior de Investigaciones Cientificas Pipeline Products and Ongoing Clinical Trials Overview 42
5.12 Corium International, Inc. Company Overview 44
5.12.1 Corium International, Inc. Pipeline Products and Ongoing Clinical Trials Overview 44
5.13 Edixomed Ltd Company Overview 46
5.13.1 Edixomed Ltd Pipeline Products and Ongoing Clinical Trials Overview 46
5.14 FzioMed, Inc. Company Overview 54
5.14.1 FzioMed, Inc. Pipeline Products and Ongoing Clinical Trials Overview 54
5.15 Halscion, Inc. Company Overview 57
5.15.1 Halscion, Inc. Pipeline Products and Ongoing Clinical Trials Overview 57
5.16 HyperBranch Medical Technology, Inc. Company Overview 60
5.16.1 HyperBranch Medical Technology, Inc. Pipeline Products and Ongoing Clinical Trials Overview 60
5.17 InVivo Therapeutics Corporation Company Overview 61
5.17.1 InVivo Therapeutics Corporation Pipeline Products and Ongoing Clinical Trials Overview 61
5.18 IPI Singapore Company Overview 62
5.18.1 IPI Singapore Pipeline Products and Ongoing Clinical Trials Overview 62
5.19 KeraNetics, LLC Company Overview 64
5.19.1 KeraNetics, LLC Pipeline Products and Ongoing Clinical Trials Overview 64
5.20 Maxigen Biotech Inc. Company Overview 66
5.20.1 Maxigen Biotech Inc. Pipeline Products and Ongoing Clinical Trials Overview 66
5.21 Medtric Biotech, LLC Company Overview 68
5.21.1 Medtric Biotech, LLC Pipeline Products and Ongoing Clinical Trials Overview 68
5.22 Newcastle University Company Overview 69
5.22.1 Newcastle University Pipeline Products and Ongoing Clinical Trials Overview 69
5.23 Northwestern University Company Overview 70
5.23.1 Northwestern University Pipeline Products and Ongoing Clinical Trials Overview 70
5.24 Oculus Innovative Sciences, Inc. Company Overview 73
5.24.1 Oculus Innovative Sciences, Inc. Pipeline Products and Ongoing Clinical Trials Overview 73
5.25 Oxtex Limited Company Overview 76
5.25.1 Oxtex Limited Pipeline Products and Ongoing Clinical Trials Overview 76
5.26 Pharmagenix AG Company Overview 77
5.26.1 Pharmagenix AG Pipeline Products and Ongoing Clinical Trials Overview 77
5.27 Piramal Enterprises Limited Company Overview 78
5.27.1 Piramal Enterprises Limited Pipeline Products and Ongoing Clinical Trials Overview 78
5.28 Plurogen Therapeutics, Inc. Company Overview 80
5.28.1 Plurogen Therapeutics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 80
5.29 Quick-Med Technologies, Inc. Company Overview 81
5.29.1 Quick-Med Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 81
5.30 Surgical Specialties Corporation (Inactive) Company Overview 83
5.30.1 Surgical Specialties Corporation (Inactive) Pipeline Products and Ongoing Clinical Trials Overview 83
5.31 Tel Aviv University Company Overview 84
5.31.1 Tel Aviv University Pipeline Products and Ongoing Clinical Trials Overview 84
5.32 The Johns Hopkins University Company Overview 85
5.32.1 The Johns Hopkins University Pipeline Products and Ongoing Clinical Trials Overview 85
5.33 The University of Queensland Company Overview 86
5.33.1 The University of Queensland Pipeline Products and Ongoing Clinical Trials Overview 86
5.34 University of Akron Company Overview 88
5.34.1 University of Akron Pipeline Products and Ongoing Clinical Trials Overview 88
5.35 University of California, San Diego Company Overview 89
5.35.1 University of California, San Diego Pipeline Products and Ongoing Clinical Trials Overview 89
5.36 Ventrix, Inc. Company Overview 90
5.36.1 Ventrix, Inc. Pipeline Products and Ongoing Clinical Trials Overview 90
5.37 Zeomedix, LLC Company Overview 91
5.37.1 Zeomedix, LLC Pipeline Products and Ongoing Clinical Trials Overview 91
6 Hydrogels- Recent Developments 92
7 Appendix 106
7.1 Methodology 106
7.2 About GlobalData 108
7.3 Contact Us 109
7.4 Disclaimer 109

1.1 List of Tables
Table 1: Hydrogels - Pipeline Products by Stage of Development 11
Table 2: Hydrogels - Pipeline Products by Segment 12
Table 3: Hydrogels - Pipeline Products by Territory 13
Table 4: Hydrogels - Pipeline Products by Regulatory Path 14
Table 5: Hydrogels - Pipeline Products by Estimated Approval Date 15
Table 6: Hydrogels - Ongoing Clinical Trials 16
Table 7: Hydrogels Companies - Pipeline Products by Stage of Development 17
Table 8: Hydrogels - Pipeline Products by Stage of Development 19
Table 9: 3QMatrix, Inc. Pipeline Products and Ongoing Clinical Trials Overview 21
Table 10: Bi-layer Dressing - Product Status 21
Table 11: Bi-layer Dressing - Product Description 21
Table 12: Abeona Therapeutics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 22
Table 13: BenzaGard - Product Status 23
Table 14: BenzaGard - Product Description 23
Table 15: Alafair Biosciences, Inc. Pipeline Products and Ongoing Clinical Trials Overview 24
Table 16: Alafair Bilayer - Product Status 25
Table 17: Alafair Bilayer - Product Description 25
Table 18: Alafair Film - Product Status 26
Table 19: Alafair Film - Product Description 26
Table 20: Alafair Injectable Gel - Product Status 27
Table 21: Alafair Injectable Gel - Product Description 27
Table 22: Alafair Membrane - Product Status 28
Table 23: Alafair Membrane - Product Description 28
Table 24: Asana Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 29
Table 25: ExtraCellular Matrix Hydrogel - Product Status 29
Table 26: ExtraCellular Matrix Hydrogel - Product Description 29
Table 27: BioCure, Inc. Pipeline Products and Ongoing Clinical Trials Overview 30
Table 28: BCNP - Product Status 31
Table 29: BCNP - Product Description 31
Table 30: Growth Factor Delivery - Hydrogel Wound Dressing - Product Status 32
Table 31: Growth Factor Delivery - Hydrogel Wound Dressing - Product Description 32
Table 32: Spray-On dressings - Product Status 33
Table 33: Spray-On dressings - Product Description 33
Table 34: Biomendics, LLC Pipeline Products and Ongoing Clinical Trials Overview 34
Table 35: Wound Gel - Product Status 34
Table 36: Wound Gel - Product Description 34
Table 37: BioTime, Inc. Pipeline Products and Ongoing Clinical Trials Overview 35
Table 38: ReGlyde - Product Status 36
Table 39: ReGlyde - Product Description 36
Table 40: Brigham and Women's Hospital Pipeline Products and Ongoing Clinical Trials Overview 37
Table 41: ELP Hydrogel - Product Status 37
Table 42: ELP Hydrogel - Product Description 37
Table 43: CelaCare Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 38
Table 44: OTC Antimicrobial Gel - Product Status 38
Table 45: OTC Antimicrobial Gel - Product Description 38
Table 46: Prescription Gel 1 - Product Status 39
Table 47: Prescription Gel 1 - Product Description 39
Table 48: Prescription Gel 2 - Product Status 40
Table 49: Prescription Gel 2 - Product Description 40
Table 50: Chi2Gel Ltd. Pipeline Products and Ongoing Clinical Trials Overview 41
Table 51: Chi2Gel Wound Dressing - Product Status 41
Table 52: Chi2Gel Wound Dressing - Product Description 41
Table 53: Consejo Superior de Investigaciones Cientificas Pipeline Products and Ongoing Clinical Trials Overview 42
Table 54: Multicomponent Hydrogel - Product Status 43
Table 55: Multicomponent Hydrogel - Product Description 43
Table 56: Corium International, Inc. Pipeline Products and Ongoing Clinical Trials Overview 44
Table 57: Hydrogel Dressing - Product Status 45
Table 58: Hydrogel Dressing - Product Description 45
Table 59: Edixomed Ltd Pipeline Products and Ongoing Clinical Trials Overview 46
Table 60: NOx Dressing - Burns - Product Status 46
Table 61: NOx Dressing - Burns - Product Description 46
Table 62: NOx Dressing - Diabetic Foot Ulcer - Product Status 47
Table 63: NOx Dressing - Diabetic Foot Ulcer - Product Description 47
Table 64: NOx Dressing - Pressure Ulcers - Product Status 48
Table 65: NOx Dressing - Pressure Ulcers - Product Description 48
Table 66: NOx Dressing - Surgical Wounds - Product Status 49
Table 67: NOx Dressing - Surgical Wounds - Product Description 49
Table 68: NOx Dressing - Venous Leg Ulcers - Product Status 50
Table 69: NOx Dressing - Venous Leg Ulcers - Product Description 50
Table 70: Edixomed Ltd - Ongoing Clinical Trials Overview 51
Table 71: NOx Dressing - Diabetic Foot Ulcer - A Clinical Pilot Study of an Oxides of Nitrogen Generating Gel Dressing System to Stimulate Healing in Diabetic Foot Ulcers 52
Table 72: NOx Dressing - Burns - A Clinical Study of Superficial Partial Thickness Wound Treatment with an Oxides of Nitrogen Generating Gel Dressing - ProNOx 2 53
Table 73: FzioMed, Inc. Pipeline Products and Ongoing Clinical Trials Overview 54
Table 74: Oxiplex/SP Gel - Product Status 54
Table 75: Oxiplex/SP Gel - Product Description 54
Table 76: FzioMed, Inc. - Ongoing Clinical Trials Overview 55
Table 77: Oxiplex/SP Gel - A Bioresorbable Product Designed To Reduce Adhesions From Lumbar Surgery: A Clinical Study 56
Table 78: Halscion, Inc. Pipeline Products and Ongoing Clinical Trials Overview 57
Table 79: Celotres - Product Status 57
Table 80: Celotres - Product Description 57
Table 81: Halscion, Inc. - Ongoing Clinical Trials Overview 58
Table 82: Celotres - A Post Market Clinical Study Evaluating the Safety, Device Performance and Possible Emergent Risks of Celotres in the Improvement of Wound Healing and the Resulting Scar Consequences Following Suturing of a Wound 59
Table 83: HyperBranch Medical Technology, Inc. Pipeline Products and Ongoing Clinical Trials Overview 60
Table 84: Adherus MIS - Product Status 60
Table 85: Adherus MIS - Product Description 60
Table 86: InVivo Therapeutics Corporation Pipeline Products and Ongoing Clinical Trials Overview 61
Table 87: Injectable Hydrogel - Fibrosis - Product Status 61
Table 88: Injectable Hydrogel - Fibrosis - Product Description 61
Table 89: IPI Singapore Pipeline Products and Ongoing Clinical Trials Overview 62
Table 90: Hyaluronic Acid-Based Gel - Product Status 62
Table 91: Hyaluronic Acid-Based Gel - Product Description 62
Table 92: Keratin Hydrogel - Product Status 63
Table 93: Keratin Hydrogel - Product Description 63
Table 94: KeraNetics, LLC Pipeline Products and Ongoing Clinical Trials Overview 64
Table 95: KeraStat Burn Gel - Product Status 64
Table 96: KeraStat Burn Gel - Product Description 64
Table 97: Keratin-Based Hydrogel Wound Dressing - Product Status 65
Table 98: Keratin-Based Hydrogel Wound Dressing - Product Description 65
Table 99: Maxigen Biotech Inc. Pipeline Products and Ongoing Clinical Trials Overview 66
Table 100: MaxiGel - Product Status 67
Table 101: MaxiGel - Product Description 67
Table 102: Medtric Biotech, LLC Pipeline Products and Ongoing Clinical Trials Overview 68
Table 103: Osmotec - Traditional Gel - Product Status 68
Table 104: Osmotec - Traditional Gel - Product Description 68
Table 105: Newcastle University Pipeline Products and Ongoing Clinical Trials Overview 69
Table 106: Synthetic ECM Hydrogel - Product Status 69
Table 107: Synthetic ECM Hydrogel - Product Description 69
Table 108: Northwestern University Pipeline Products and Ongoing Clinical Trials Overview 70
Table 109: Biocompatible Hydrogel - Product Status 70
Table 110: Biocompatible Hydrogel - Product Description 70
Table 111: pH Responsive Self-Healing Hydrogel - Product Status 71
Table 112: pH Responsive Self-Healing Hydrogel - Product Description 71
Table 113: Tissue Sealant - Fetal Membrane Repair - Product Status 72
Table 114: Tissue Sealant - Fetal Membrane Repair - Product Description 72
Table 115: Oculus Innovative Sciences, Inc. Pipeline Products and Ongoing Clinical Trials Overview 73
Table 116: Dermacyn SkinGuard Hydrogel - Product Status 74
Table 117: Dermacyn SkinGuard Hydrogel - Product Description 74
Table 118: Dermacyn Wound Care Hydrogel - Product Status 75
Table 119: Dermacyn Wound Care Hydrogel - Product Description 75
Table 120: Oxtex Limited Pipeline Products and Ongoing Clinical Trials Overview 76
Table 121: Oxtex Tissue Expander - Product Status 76
Table 122: Oxtex Tissue Expander - Product Description 76
Table 123: Pharmagenix AG Pipeline Products and Ongoing Clinical Trials Overview 77
Table 124: PGX-10 - Product Status 77
Table 125: PGX-10 - Product Description 77
Table 126: Piramal Enterprises Limited Pipeline Products and Ongoing Clinical Trials Overview 78
Table 127: BST-DermOn - Product Status 79
Table 128: BST-DermOn - Product Description 79
Table 129: Plurogen Therapeutics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 80
Table 130: PluroGel PNN - Product Status 80
Table 131: PluroGel PNN - Product Description 80
Table 132: Quick-Med Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 81
Table 133: Nimbus Hydrogel - Product Status 82
Table 134: Nimbus Hydrogel - Product Description 82
Table 135: Surgical Specialties Corporation (Inactive) Pipeline Products and Ongoing Clinical Trials Overview 83
Table 136: Adhibit - Product Status 83
Table 137: Adhibit - Product Description 83
Table 138: Tel Aviv University Pipeline Products and Ongoing Clinical Trials Overview 84
Table 139: Self Assembled Peptide Hydrogel (SAPH) - Product Status 84
Table 140: Self Assembled Peptide Hydrogel (SAPH) - Product Description 84
Table 141: The Johns Hopkins University Pipeline Products and Ongoing Clinical Trials Overview 85
Table 142: Chondroitin Sulfate Hydrogel - Product Status 85
Table 143: Chondroitin Sulfate Hydrogel - Product Description 85
Table 144: The University of Queensland Pipeline Products and Ongoing Clinical Trials Overview 86
Table 145: Peptide Hydrogel - Product Status 87
Table 146: Peptide Hydrogel - Product Description 87
Table 147: University of Akron Pipeline Products and Ongoing Clinical Trials Overview 88
Table 148: OXAID Hydrogel Wound Dressing - Product Status 88
Table 149: OXAID Hydrogel Wound Dressing - Product Description 88
Table 150: University of California, San Diego Pipeline Products and Ongoing Clinical Trials Overview 89
Table 151: Self Healing Hydrogel - Product Status 89
Table 152: Self Healing Hydrogel - Product Description 89
Table 153: Ventrix, Inc. Pipeline Products and Ongoing Clinical Trials Overview 90
Table 154: VentriGel - Product Status 90
Table 155: VentriGel - Product Description 90
Table 156: Zeomedix, LLC Pipeline Products and Ongoing Clinical Trials Overview 91
Table 157: Zeomedix Hydrogel - Product Status 91
Table 158: Zeomedix Hydrogel - Product Description 91
Table 159: Glossary 107

1.2 List of Figures
Figure 1: Hydrogels - Pipeline Products by Stage of Development 11
Figure 2: Hydrogels - Pipeline Products by Segment 12
Figure 3: Hydrogels - Pipeline Products by Territory 13
Figure 4: Hydrogels - Pipeline Products by Regulatory Path 14
Figure 5: Hydrogels - Pipeline Products by Estimated Approval Date 15
Figure 6: Hydrogels - Ongoing Clinical Trials 16

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H2 2016

Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline ...

70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Pipeline Review, H2 2016

70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Pipeline Review, ...

Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Pipeline Review, H2 2016

Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Pipeline Review, H2 2016 Summary Global ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.